Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$3.29B |
| 2 |
Palo Alto Networks
PANW
|
+$524M |
| 3 |
Broadcom
AVGO
|
+$416M |
| 4 |
Qualcomm
QCOM
|
+$412M |
| 5 |
Tesla
TSLA
|
+$391M |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.21B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$662M |
| 3 |
Apple
AAPL
|
+$607M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
Meta Platforms (Facebook)
META
|
+$523M |
Sector Composition
| 1 | Technology | 26.37% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 12.19% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
BWX Technologies
BWXT
$15.4B
| $9.85M | ﹤0.01% |
205,649
+16,310
| +9% | +$781K |
|
1702
ICU Medical
ICUI
$3.22B
| $9.84M | ﹤0.01% |
41,475
+3,610
| +10% | +$857K |
|
1703
Vital Farms
VITL
$2.17B
| $9.83M | ﹤0.01% |
544,448
-35,027
| -6% | -$633K |
|
1704
Methode Electronics
MEI
$287M
| $9.83M | ﹤0.01% |
199,935
+884
| +0.4% | +$43.5K |
|
1705
Revolve Group
RVLV
$1.59B
| $9.81M | ﹤0.01% |
175,080
-5,835
| -3% | -$327K |
|
1706
Addus HomeCare
ADUS
$2.03B
| $9.8M | ﹤0.01% |
104,773
-6,556
| -6% | -$613K |
|
|
XENT
1707
DELISTED
Intersect ENT, Inc
XENT
| $9.79M | ﹤0.01% |
358,364
-11,078
| -3% | -$303K |
|
1708
Vodafone
VOD
$28.5B
| $9.77M | ﹤0.01% |
654,544
+169,751
| +35% | +$2.53M |
|
1709
SAP
SAP
$299B
| $9.75M | ﹤0.01% |
69,605
-15,688
| -18% | -$2.2M |
|
1710
Kirby Corp
KEX
$4.8B
| $9.75M | ﹤0.01% |
164,016
-11,656
| -7% | -$693K |
|
|
FSR
1711
DELISTED
Fisker Inc.
FSR
| $9.74M | ﹤0.01% |
581,690
+18,708
| +3% | +$313K |
|
1712
Hope Bancorp
HOPE
$1.4B
| $9.72M | ﹤0.01% |
660,479
-34,371
| -5% | -$506K |
|
1713
Dutch Bros
BROS
$8.2B
| $9.64M | ﹤0.01% |
189,433
-9,517
| -5% | -$485K |
|
1714
News Corp Class B
NWS
$18.2B
| $9.63M | ﹤0.01% |
427,777
-88,095
| -17% | -$1.98M |
|
1715
Nu Skin
NUS
$596M
| $9.62M | ﹤0.01% |
204,626
-16,169
| -7% | -$760K |
|
1716
Arcosa
ACA
$4.67B
| $9.6M | ﹤0.01% |
181,752
-128,902
| -41% | -$6.81M |
|
1717
Assured Guaranty
AGO
$3.93B
| $9.59M | ﹤0.01% |
191,118
-19,704
| -9% | -$989K |
|
|
ATRS
1718
DELISTED
Antares Pharma, Inc.
ATRS
| $9.59M | ﹤0.01% |
2,686,553
-66,987
| -2% | -$239K |
|
1719
Encore Capital Group
ECPG
$1.02B
| $9.59M | ﹤0.01% |
166,609
+10,520
| +7% | +$605K |
|
1720
Health Catalyst
HCAT
$220M
| $9.58M | ﹤0.01% |
261,890
-34,717
| -12% | -$1.27M |
|
1721
LoveSac
LOVE
$258M
| $9.58M | ﹤0.01% |
144,558
+35,127
| +32% | +$2.33M |
|
1722
Digi International
DGII
$1.33B
| $9.57M | ﹤0.01% |
389,568
-12,690
| -3% | -$312K |
|
|
MODV
1723
DELISTED
ModivCare
MODV
| $9.54M | ﹤0.01% |
64,295
-15,819
| -20% | -$2.35M |
|
1724
Cytokinetics
CYTK
$6.12B
| $9.51M | ﹤0.01% |
260,290
-22,259
| -8% | -$814K |
|
1725
Timken Company
TKR
$5.4B
| $9.49M | ﹤0.01% |
137,018
+14,586
| +12% | +$1.01M |
|